세계의 CRISPR 기술 시장 : 제품, 용도, 최종 사용자별 예측(2025-2030년)

The CRISPR Technology Market was valued at USD 3.25 billion in 2023, expected to reach USD 3.77 billion in 2024, and is projected to grow at a CAGR of 16.52%, to USD 9.49 billion by 2030.

CRISPR technology, a groundbreaking tool for gene editing, has revolutionized the fields of genetics and biotechnology by allowing precise modifications to DNA. Its scope encompasses a vast range of applications including therapeutic gene editing for genetic disorders, agricultural advancements through crop genome modification, and the development of genetically engineered models for research purposes. The necessity for CRISPR technology is driven by its potential to address unmet medical needs, improve agricultural productivity, and facilitate scientific research. End-use sectors include healthcare, agriculture, and biotechnology industries, each leveraging the technology to enhance product offerings and innovations.

Market growth is influenced by the increasing prevalence of genetic disorders that necessitate novel therapeutic approaches, advancements in agricultural biotechnology to ensure food security, and substantial investments in R&D from both public and private entities. Potential opportunities lie in expanding CRISPR applications beyond therapeutics and agriculture into areas like biofuel production and environmental management. To capitalize on these opportunities, companies should focus on strategic partnerships and collaborations, agile integration of AI in genomics for precision editing, and development of robust delivery systems for gene therapies.

However, the market faces challenges such as ethical and safety concerns, stringent regulatory frameworks, and the complex nature of intellectual property rights pertaining to CRISPR patents. Overcoming these challenges requires comprehensive stakeholder engagement to address ethical issues, navigating regulatory pathways efficiently, and establishing strong IP management strategies. Areas of innovation and research ripe for exploration include enhancing CRISPR specificity and efficiency, developing novel delivery mechanisms, and exploring therapeutic applications in less-studied or rare genetic conditions. Overall, the CRISPR technology market is dynamic, driven by innovation, with substantial opportunities for businesses that can navigate the regulatory landscape and address ethical considerations effectively while pushing forward technological boundaries.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving CRISPR Technology Market

The CRISPR Technology Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Growing need for new vaccines and treatments for genetic diseases
  • Increasing private and public investments in biotechnological and pharmaceutical sectors
• Market Restraints
  • High cost and complexities involved in the government regulations
• Market Opportunities
  • Advancements and improvements in CRISPR technology
  • Potential use of CRISPR technology in the agriculture sector
• Market Challenges
  • Technical challenges and ethical concerns associated with CRISPR technology

Porter's Five Forces: A Strategic Tool for Navigating the CRISPR Technology Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the CRISPR Technology Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the CRISPR Technology Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the CRISPR Technology Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the CRISPR Technology Market

A detailed market share analysis in the CRISPR Technology Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the CRISPR Technology Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the CRISPR Technology Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Key Company Profiles

The report delves into recent significant developments in the CRISPR Technology Market, highlighting leading vendors and their innovative profiles. These include Agilent Technologies, Inc., Applied StemCell, Inc., Beam Therapeutics Inc., Caribou Biosciences, Inc., Cellectis S.A., CRISPR Therapeutics AG, Danaher Corporation, Editas Medicine, Inc., ERS Genomics Limited, Function Oncology, GeneCopoeia, Inc., GenScript Biotech Corporation, Horizon Discovery Group Ltd. by Revvity, Inc., Inscripta, Inc., Intellia Therapeutics, Inc., Lonza Group Ltd., Mammoth Biosciences, Inc., Merck KGaA, New England Biolabs, Inc., OriGene Technologies, Inc., Prime Medicine, Inc., Scribe Therapeutics, Sherlock Biosciences, Inc., Synthego Corporation, Takara Holdings Inc., Thermo Fisher Scientific Inc., ToolGen, Inc., TriLink BioTechnologies by Maravai Intermediate Holdings, LLC, Twist Bioscience Corporation, and Verve Therapeutics, Inc..

Market Segmentation & Coverage

This research report categorizes the CRISPR Technology Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Offering, market is studied across Product and Services. The Product is further studied across Enzymes, Guide RNA, and Kits & Reagents. The Services is further studied across Cell Line Engineering, gRNA Design & Vector Construction, and Screening Services.
• Based on Application, market is studied across Agricultural, Biomedical, and Industrial.
• Based on End User, market is studied across Academics & Government Research Institutes and Biotechnology Companies. The Biotechnology Companies is further studied across Agricultural Companies and Pharmaceutical Companies.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Georgia, Illinois, Kentucky, Michigan, Mississippi, New Jersey, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Growing need for new vaccines and treatments for genetic diseases
    • 5.1.1.2. Increasing private and public investments in biotechnological and pharmaceutical sectors
  • 5.1.2. Restraints
    • 5.1.2.1. High cost and complexities involved in the government regulations
  • 5.1.3. Opportunities
    • 5.1.3.1. Advancements and improvements in CRISPR technology
    • 5.1.3.2. Potential use of CRISPR technology in the agriculture sector
  • 5.1.4. Challenges
    • 5.1.4.1. Technical challenges and ethical concerns associated with CRISPR technology
• 5.2. Market Segmentation Analysis
  • 5.2.1. Offering: Increasing use of CRISPR kits & reagents with the surging research activities and product improvements
  • 5.2.2. Application: Proliferating use of CRISPR technology in the agricultural sector
  • 5.2.3. End-User: Potential application of CRISPR technology in biotechnology companies
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental
• 5.5. Client Customization
  • 5.5.1. CRISPR becoming a viable solution for bioenergy production
  • 5.5.2. Expanding patent landscape for CRISPR technology

6. CRISPR Technology Market, by Offering

• 6.1. Introduction
• 6.2. Product
  • 6.2.1. Enzymes
  • 6.2.2. Guide RNA
  • 6.2.3. Kits & Reagents
• 6.3. Services
  • 6.3.1. Cell Line Engineering
  • 6.3.2. gRNA Design & Vector Construction
  • 6.3.3. Screening Services

7. CRISPR Technology Market, by Application

• 7.1. Introduction
• 7.2. Agricultural
• 7.3. Biomedical
• 7.4. Industrial

8. CRISPR Technology Market, by End User

• 8.1. Introduction
• 8.2. Academics & Government Research Institutes
• 8.3. Biotechnology Companies
  • 8.3.1. Agricultural Companies
  • 8.3.2. Pharmaceutical Companies

9. Americas CRISPR Technology Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific CRISPR Technology Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa CRISPR Technology Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
  • 12.3.1. RoslinCT Manufacture CRISPR-Based Therapy
  • 12.3.2. First Human CRISPR Drug Moves Forward
  • 12.3.3. ERS Genomics Limited ('ERS') Completes Licensing Agreement With Syngene International
  • 12.3.4. Revvity's (RVTY) New Launch to Widen Access to Editing Technology
  • 12.3.5. Pencil Biosciences Raises GBP 5.6 Million to Advance Gene Editing for Rare Diseases
  • 12.3.6. Integrated DNA Technologies and Aldevron Activate Strategic Partnership to Deliver Key CRISPR Components to Cell and Gene Therapy Developers
  • 12.3.7. Bedoukian Research Inc. Partners with Inscripta to Sustainably Develop and Manufacture Naturally Produced Ingredients
  • 12.3.8. Scribe Announces Collaboration to Accelerate In Vivo CRISPR-Based Genetic Medicines
  • 12.3.9. Vertex Teases Launch Plans for First Crispr Gene Editing Therapy Ahead of FDA Decision
  • 12.3.10. Sherlock Biosciences to Acquire Sense Biodetection
  • 12.3.11. Intellia Therapeutics Announces Acquisition of Rewrite Therapeutics

Companies Mentioned

• 1. Agilent Technologies, Inc.
• 2. Applied StemCell, Inc.
• 3. Beam Therapeutics Inc.
• 4. Caribou Biosciences, Inc.
• 5. Cellectis S.A.
• 6. CRISPR Therapeutics AG
• 7. Danaher Corporation
• 8. Editas Medicine, Inc.
• 9. ERS Genomics Limited
• 10. Function Oncology
• 11. GeneCopoeia, Inc.
• 12. GenScript Biotech Corporation
• 13. Horizon Discovery Group Ltd. by Revvity, Inc.
• 14. Inscripta, Inc.
• 15. Intellia Therapeutics, Inc.
• 16. Lonza Group Ltd.
• 17. Mammoth Biosciences, Inc.
• 18. Merck KGaA
• 19. New England Biolabs, Inc.
• 20. OriGene Technologies, Inc.
• 21. Prime Medicine, Inc.
• 22. Scribe Therapeutics
• 23. Sherlock Biosciences, Inc.
• 24. Synthego Corporation
• 25. Takara Holdings Inc.
• 26. Thermo Fisher Scientific Inc.
• 27. ToolGen, Inc.
• 28. TriLink BioTechnologies by Maravai Intermediate Holdings, LLC
• 29. Twist Bioscience Corporation
• 30. Verve Therapeutics, Inc.